Quantinno Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Quantinno Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.23M	Buy	22,223 +2,331	+12%	+$401K	0.01%	1389
2026 Q1	$3.36M	Buy	19,892 +4,939	+33%	+$845K	0.01%	1328
2025 Q4	$2.52M	Buy	14,953 +8,871	+146%	+$1.44M	0.01%	1284
2025 Q3	$878K	Buy	6,082 +1,764	+41%	+$241K	﹤0.01%	1570
2025 Q2	$546K	Buy	4,318 +2,454	+132%	+$301K	﹤0.01%	1598
2025 Q1	$238K	Buy	+1,864	New	+$253K	﹤0.01%	1756
2024 Q4	–	Sell	-1,679	Closed	-$244K	–	1661
2024 Q3	$244K	Buy	+1,679	New	+$243K	﹤0.01%	1333

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Quantinno Capital Management's IBB Position: Q2 2026 in Review

Quantinno Capital Management increased its iShares Biotechnology ETF (IBB) stake by 12% in Q2 2026, buying an estimated $401K and bringing the position to 22,223 shares worth $4.23M. The position accounts for 0.01% of the portfolio, ranked #1389.

Quantinno Capital Management first reported a position in IBB in Q3 2024 and has held it in 7 quarters since. 958 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Quantinno Capital Management held 22,223 shares of iShares Biotechnology ETF worth $4.23M as of Q2 2026.
Quantinno Capital Management bought 2,331 iShares Biotechnology ETF shares in Q2 2026, an estimated $401K.
iShares Biotechnology ETF made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1389 holding.
Quantinno Capital Management first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 7 quarters since.
958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.